{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:20:04Z","timestamp":1784841604739,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","award":["B25871132"],"award-info":[{"award-number":["B25871132"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development, AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"JST CREST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15KT0147"],"award-info":[{"award-number":["15KT0147"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15H05707"],"award-info":[{"award-number":["15H05707"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["16K052565"],"award-info":[{"award-number":["16K052565"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["16KT0111"],"award-info":[{"award-number":["16KT0111"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15KT0107"],"award-info":[{"award-number":["15KT0107"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["26287025"],"award-info":[{"award-number":["26287025"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["16H04845"],"award-info":[{"award-number":["16H04845"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["16K13777"],"award-info":[{"award-number":["16K13777"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS Bilateral Joint Research Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003844","name":"Inamori Foundation Research Grant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008608","name":"Sumitomo Foundation Research Grant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"Senshin Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Imai Memorial Trust for AIDS Research"},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST PRESTO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitsui Life Social Welfare Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.antiviral.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T01:02:53Z","timestamp":1476579773000},"page":"62-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Modelling Ebola virus dynamics: Implications for therapy"],"prefix":"10.1016","volume":"135","author":[{"given":"Alexey","family":"Martyushev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.10.004_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/524013a","article-title":"How Ebola-vaccine success could reshape clinical-trial policy","volume":"524","author":"Butler","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.10.004_bib4","doi-asserted-by":"crossref","first-page":"e1002057","DOI":"10.1371\/journal.pbio.1002057","article-title":"Characterizing the transmission dynamics and control of ebola virus disease","volume":"13","author":"Chowell","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.346.6212.911","article-title":"Saving lives without new drugs","volume":"346","author":"Cohen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.004_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.346.6212.908","article-title":"A\u00a0dose of reality","volume":"346","author":"Cohen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.004_bib7","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.179.9.6107","article-title":"TLR4\/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock","volume":"179","author":"Daubeuf","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.qai.0000199232.31340.d3","article-title":"Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection","volume":"41","author":"Davenport","year":"2006","journal-title":"J.\u00a0Acquir Immune Defic. Syndr."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.10.004_bib9","doi-asserted-by":"crossref","first-page":"S991","DOI":"10.1093\/infdis\/jir336","article-title":"Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus","volume":"204","author":"Ebihara","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib10","doi-asserted-by":"crossref","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-Perez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.10.004_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.10.004_bib12","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.10.004_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7861\/clinmedicine.15-1-61","article-title":"Viral haemorrhagic fever","volume":"15","author":"Fhogartaigh","year":"2015","journal-title":"Clin. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","article-title":"Administration of brincidofovir and convalescent plasma in a patient with ebola virus disease","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib15","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.10.004_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ajh.20296","article-title":"Dendritic cell counts in the peripheral blood of healthy adults","volume":"78","author":"Haller Hasskamp","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib18","first-page":"205","article-title":"Immune response to filovirus infections","volume":"235","author":"Ignatyev","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-4682-11-22","article-title":"Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model","volume":"11","author":"Ikeda","year":"2014","journal-title":"Theor. Biol. Med. Model"},{"key":"10.1016\/j.antiviral.2016.10.004_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fmicb.2012.00319","article-title":"Identifying viral parameters from in\u00a0vitro cell cultures","volume":"3","author":"Iwami","year":"2012","journal-title":"Front. Microbiol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2016.10.004_bib21","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/phar.1545","article-title":"Treatment of ebola virus disease","volume":"35","author":"Kilgore","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.antiviral.2016.10.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/fmb.11.110","article-title":"Ebolavirus: a brief review of novel therapeutic targets","volume":"7","author":"Kondratowicz","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2016.10.004_bib25","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/514294","article-title":"Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections","volume":"179","author":"Kudoyarova-Zubavichene","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.347.6223.701","article-title":"Infectious diseases. Ebola drug trials lurch ahead","volume":"347","author":"Kupferschmidt","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.004_bib27","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMoa1409838","article-title":"Clinical care of two patients with Ebola virus disease in the United States","volume":"371","author":"Lyon","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2015.08.015","article-title":"Ebola virus dynamics in mice treated with favipiravir","volume":"123","author":"Madelain","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.004_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaa4919","article-title":"Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates","volume":"348","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.10.004_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome","volume":"210","author":"McElroy","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annemergmed.2014.10.009","article-title":"Ebola virus outbreak 2014: clinical review for emergency physicians","volume":"65","author":"Meyers","year":"2015","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib32","series-title":"Virus Dynamics","author":"Nowak","year":"2000"},{"key":"10.1016\/j.antiviral.2016.10.004_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.004_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics","volume":"2","author":"Perelson","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib35","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1128\/JVI.01596-08","article-title":"Estimating the impact of vaccination on acute simian-human immunodeficiency virus\/simian immunodeficiency virus infections","volume":"82","author":"Petravic","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006608","article-title":"Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail","volume":"5","author":"Pettitt","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.10.004_bib38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.1259595","article-title":"Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance","volume":"346","author":"Rasmussen","year":"2014","journal-title":"Science"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2016.10.004_bib39","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/514293","article-title":"An analysis of features of pathogenesis in two animal models of Ebola virus infection","volume":"179","author":"Ryabchikova","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2172-11-30","article-title":"Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults","volume":"11","author":"Seidler","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.004_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jtbi.2000.1076","article-title":"Modeling plasma virus concentration during primary HIV infection","volume":"203","author":"Stafford","year":"2000","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fmicb.2012.00034","article-title":"Filovirus tropism: cellular molecules for viral entry","volume":"3","author":"Takada","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib44","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib45","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.10.004_bib47","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1128\/JVI.01771-06","article-title":"Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut","volume":"81","author":"Wilson","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2014.04.002","article-title":"Post-exposure therapy of filovirus infections","volume":"22","author":"Wong","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.10.004_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M14-2255","article-title":"Effect of Ebola progression on transmission and control in Liberia","volume":"162","author":"Yamin","year":"2015","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.antiviral.2016.10.004_bib50","first-page":"97","article-title":"Pathologic features of filovirus infections in humans","volume":"235","author":"Zaki","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:40Z","timestamp":1759062400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"alternative-id":["S0166354216303473"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling Ebola virus dynamics: Implications for therapy","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}